01 1Viatris
01 1AMBRISENTAN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-20
Pay. Date : 2014-04-15
DMF Number : 24505
Submission : 2010-12-21
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMBRISENTAN, with a corresponding US DMF Number 24505.
Remarkably, this DMF maintains an Active status since its submission on December 21, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2014, and payment made on April 15, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
